G. Abignano Et Al. , "UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis," JOURNAL OF RHEUMATOLOGY , vol.48, no.9, pp.1422-1426, 2021
Abignano, G. Et Al. 2021. UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis. JOURNAL OF RHEUMATOLOGY , vol.48, no.9 , 1422-1426.
Abignano, G., Mennillo, G. A., Lettieri, G., Temiz Karadag, D., Carriero, A., Padula, A. A., ... Del Galdo, F.(2021). UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis. JOURNAL OF RHEUMATOLOGY , vol.48, no.9, 1422-1426.
Abignano, Giuseppina Et Al. "UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis," JOURNAL OF RHEUMATOLOGY , vol.48, no.9, 1422-1426, 2021
Abignano, Giuseppina Et Al. "UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis." JOURNAL OF RHEUMATOLOGY , vol.48, no.9, pp.1422-1426, 2021
Abignano, G. Et Al. (2021) . "UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis." JOURNAL OF RHEUMATOLOGY , vol.48, no.9, pp.1422-1426.
@article{article, author={Giuseppina Abignano Et Al. }, title={UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis}, journal={JOURNAL OF RHEUMATOLOGY}, year=2021, pages={1422-1426} }